Scancell to present at Biotech Capital

For immediate release 24 February 2016

Hygea vct plc

Scancell plc to present at Biotech Capital in London on 3rd March 2016

The Board of Hygea vct plc announces that Hygea's largest investment by value, Scancell plc (www.scancell.co.uk), is presenting at the Biotech Capital Conference being held in London on 3rd March 2016. Attendance is free, with registration via www.biotech-capital.com/conferences - a recording of the event will be posted on the website. An article Immunotherapy: a turning point in cancer treatment by Vadim Alexandre can be found on page 8 of the AIM Journal (http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).

Enquiries: Charles Breese, director on 01280 703482